The global high-content screening (HCS) market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period. The factors expected to drive the growth of the market are cost containment in pharmaceutical R&D, increasing funding for cellular research, and technological advancements in HCS solutions during the forecast period. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth to a certain extent.

The HCS instruments market accounted for the largest share of HCS market primarily attributed to advances in instrumentation and automation techniques and high prices of the HCS instruments. The software segment is expected to register the highest growth during the forecast period. The growth of this market is attributed to the technological advancements in image acquisition, data analysis, and storage capabilities and the need to obtain information on changes in cell morphology through high-quality images.

North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. High R&D expenditure, the presence of major pharmaceutical market players, and increasing government support are some of the factors contributing to the large share of North America in the market. However, the Asia-Pacific market is expected to register the highest growth during the forecast period owing to increased research in drug discovery, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure.

The major players in the high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

Research Coverage:
The market is segmented based on product, application, end user, and region. Based on product, the market is segmented into high-content screening instruments (cell imaging & analysis systems and flow cytometers), consumables (reagents & assay kits, microplates and other consumables), software, services, and accessories. Based on application, the market is segmented into target identification and validation, primary and secondary screening, toxicity studies, and compound profiling. On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, academic and government institutes, and contract research organizations. This report also provides market information on North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. These regions are further segmented at a country level.

Reasons To Buy the Report
This report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies to strengthen their market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the high-content screening market. This report analyzes the market by product, application, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming trends and product launches in the high-content screening market
  • Market Development: Comprehensive information on the lucrative emerging markets for high-content screening
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the high-content screening market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and technological capabilities of the leading players in the high-content screening market